Skip to main content
Caplight Logo









One Biosciences

One Biosciences

Private
ParisHealthcare & Life Scienceshttps://onebiosciences.fr/

Last Round

Series A

Jul 17, 2025

Total Funding Raised

$30.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

One Biosciences is a biotechnology company that provides an AI-driven, single-cell analysis platform for precision oncology.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologysingle-cell analysisAI drug discoverydrug discovery platformtechbioAI diagnosticssingle-cell transcriptomicstumor heterogeneitybiomarker discoveryoncology diagnosticspatient stratificationsingle cell sequencingclinical trial supportmedical AIFFPE sample analysissingle-cell omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One Biosciences Comparables

Compare One Biosciences with similar companies based on industry and business-model similarity.

One Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
1Cell.Ai
84%
Predicta Biosciences
78%
Immunai
76%

One Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 17, 2025
SeedSep 13, 2022
SeedJul 22, 2020

One Biosciences Investors

Notable investors and investment history

One Biosciences investors
InvestorRounds
Redmile GroupSeed, Series A
Kima VenturesSeries A
Blast.clubSeries A
Adamed TechnologySeries A
Galion.exeSeries A
Home BiosciencesSeries A, Seed
Sofinnova PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 1548% MoM, from 42 to 692.

  • Oct 1, 2025

    Partnered with Institut Curie and Gustave Roussy in France.

One Biosciences Filings

Explore SEC and related filing metadata, where available.

One Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about One Biosciences's valuation, stock price, and market status.

Is One Biosciences a public or private company?

One Biosciences is a private company.

What is the current stock price of One Biosciences?

One Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is One Biosciences worth (valuation)?

Valuation information for One Biosciences is not publicly available.

Can I buy One Biosciences stock?

One Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was One Biosciences's last funding round?

One Biosciences's most recent funding round was Series A on July 17, 2025.

Who are the main investors in One Biosciences?

Key investors in One Biosciences include Redmile Group, Blast.club.

Will One Biosciences IPO soon?

No public IPO plans have been announced for One Biosciences.

How can I track One Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor One Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range30
Year Founded2020
Last FundingJul 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?